Home > Boards > US OTC > Miscellaneous >

BioNeutral Group, Inc. (BONU)

Add BONU Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator stock_MD, roger wilco, VortMax, Meach2
Search This Board:
Last Post: 7/27/2014 10:29:22 PM - Followers: 210 - Board type: Free - Posts Today: 0


Executive Interview: BioNeutral Group CEO Mark Lowenthal
Mar 5, 2014 8:57 AM | about stocks: BONU

My executive Q & A series has been going very well. I've interviewed some great CEO's in the Small and microcap arenas. Earlier this week I was fortunate enough to have a chance to site down with Mark Lowenthal, CEO of Bioneutral Group Inc. This company was one that I had reported on a few months ago and have been following since mid November of 2013. It seems like the company has just started to build in the 2014 year and after having had the chance to discuss BONU with the company's CEO, I feel that this will be something that I'll continue to follow throughout the year:

Executive Interview with BioNeutral Group CEO Mark Lowenthal

1. In a few words, can you explain what the company does or is planning to do?

Over the last seven years our Company has developed, tested and is now in the process of commercially introducing a series of state of the art and highly competitive sterilization and bioneutralizer products (products that kill micro-organisms on surfaces and eliminate odors in the air at the cellular level). The products have wide applications in various health and life science segments (acute and long-term care, veterinary care, first response, laboratory research, pharma manufacturing), and in industrial segments (janitorial, sanitation, mold remediation, hospitality), both here at home and abroad. They also have substantial applications across various government and consumer markets as well.

With our testing substantially performed as of late 2012, we began 2013 by first accessing the various marketplaces, then developed a focused sales plan, and finally in the later part of the year began to engage independent sales agents, i.e. independent sales groups and distributors.

Overall we've found the markets extremely receptive, and beginning in 2014 we now believe we are finally beginning to be in a position to leverage our technology. To date we have been severely hampered by being undercapitalized and lacking the resources with which to do this.

2. What Direction do you see your industry headed toward?

There is a continually growing movement on a worldwide basis towards higher standards of sterility and high-level disinfection across a wide variety of market segments which we plan to engage in. In this respect, as a high quality and highly efficacious supplier we have high expectations.

3. What are the key risks the company faces right now?

We feel our chief constraint is our access is to capital. Like most small companies, locating cost effective sources of capital can be (and in the past has proven to be) somewhat tricky. However I will say we are making progress in that area and as things stand currently, I feel our prospects have improved.

4. What projects are you currently looking to begin and/or complete?

We are currently in the process of negotiating a supply agreement and a private label transaction with two major market distributors for coverage both here at home and abroad. In addition, we are also in discussions with a major distributor for a key market segment, and we are close to an agreement to begin consumer testing our Ogiene products overseas.

5. What are the current challenges you're facing that could prevent or slow progress from this/these project(s)?

As mentioned above, access to capital.

6. If all goes as planned, how much revenue does the company anticipate generating from this/these project(s)?

We are in the early stages of commercialization and in the process of collecting new market data all the time, and that being said, over the next five years or so my goal is to have the Company generate sales in the $150,000,000 range.

7. How are you currently marketing your product/brand?

By engaging with firms for supply agreements, distribution agreements, private label transactions and independent sales groups.

8. Where do you think the most significant growth will occur for the company over the next 3-6months?

Four key market segments, laboratory research, pharmaceutical and compound manufacturing, janitorial/sanitation and mold remediation

9. You're the CEO of a small cap company. What is the major discerning factor that sets the company apart from the rest and gives you a competitive advantage?

Our proprietary combinational chemistry that makes up our technology; which is highly effective, highly competitive and cost effective.

10. What are you doing to capitalize on the company's strengths and minimize the company's weakness?

We are actively engaged in micro financial markets and are accessing capital there to finance much of our operations and plan to continue to do so.

11. Are you self-funding your projects or do you work with funding sources as a means for operational cash flow?

Our goal is to become financially self-sufficient through our operations as soon as possible. At the current time we are working with a few lending sources.

12. Is there anything that shareholders should know about you personally?

I am a highly trained and fairly successful professional manager. Shareholders can find my bio on line. I am heavily invested in the company, and as such am committed to its success.

It was a pleasure speaking with Mr. Lowenthal and I would like to thank him for his time. Having had the opportunity to discuss several specific topics sheds more light on the company's direction for the new year and even beyond. Until next time,






The Importance about Spectrasan:

Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:

Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:

Read below from some older news to possibly link an affiliation:


BioTech Medical, LLC, a privately held company announced Monday that it is prepared with its new product SpectraSan 24, a new advanced surface disinfectant to immediately respond to the current Influenza A (H1N1) epidemic. BioTech Medical, LLC is a distributor for PURE Bioscience (Nasdaq: PURE), creators of the patented silver dihydrogen citrate (SDC) antimicrobial. …

PURE trades on the NASDAQ at $1.10+ per share:

These relationships are definitely something that we should keep our eye on for sure.    


Dr. Andy Kielbania, was with was Rohm and Haas which was a very huge multi-billion dollar company.  In my opinion, him being here with BONU is a huge hint that he is not here because of something that could be considered small change.  See below: 



Rohm and Haas | Company Information from ICIS

In April 2009, Dow Chemical completed its $78/share takeover of Rohm and Haas. Dow Chemical will integrate its acquired Rohm and Haas business into the newly formed ‘Advanced Materials Division’ and will be headed by Pierre Brondeau.
Dow Chemical bought out Rohm and Haas for $78.00 per share.  When you click on the old Rohm and Haas website, it takes you to Dow Chemicals website:

For inquiring minds, Dow Chemicals trade on the NYSE at $40.00+ per shareunder the ticker pf DOW:  

More proof that Dr. Andy Kielbania, PhD, CEO, Chief Scientific Officer and Director for BONU was an instrumental part of Rohm and Haas which was bought out by Dow Chemical:

At Rohm and Haas we thank Dr. Edward Firouztale, Dr. Peter Cartier, and Dr. Andy Kielbania for scholarly discussions and assistance with the research. 


Dr. Andy Kielbania, PhD 
The Chief Scientist with over 35 years experience in the specialty chemical field, including coatings, adhesives, personal care, biotechnology and pharmaceuticals. He has previously held positions at Rohm and Haas (do people realize how big these Companies are?) where he assumed senior level positions in research and development. In 1993, Dr. Kielbania joined National Starch and Chemical Company (part of ICI) as research and development Director. Dr. Kielbania is the inventor on 21 patents and has published many technical articles. He is the winner of awards in new technology development to improve new business opportunities and also research and development improvements. He received his PhD in organic chemistry from the University of California at Berkeley (good grief it does not get any better than that other than Harvard and MIT!) and has post doctoral experience at Stanford University




Disinfectant that quickly wipes out swine flu, anthrax spores, is being tested at NJIT




Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature.
            Hospital induced Staph Infection & H1N1 Flu Virus

The required EPA testing procedures occurred at ATS Labs. 




BioNeutral’s Ygiene™ Kills Dangerous MRSA in Seconds. Hospital Acquired Infections (HAI’s), The big one ( staph Infection)

BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.

MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.




BioNeutral’s Consumer Grade Ygiene™ Delivers a 100% Total Kill on Contact of Swine Flu (H1N1) Virus – For the Home



BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent ...



Swine Flu Campaign Waits on Vaccine
Only Third of Supply Is Expected for First Round of Vast Effort

By Rob Stein
Washington Post Staff Writer
Sunday, August 23, 2009




Sort by: 


New York Times

Monday, August 24, 2009



BioNeutral Group ($BONU) - June 2011  PowerPoint


BioNeutral Group Hosts Discussions with Four of the World’s Largest Health Care Companies

All Interested in Ygiene™ Sporicidal Antimicrobial Performance on Skin and Surfaces

Business Wire

Monday, August 24, 2009


211 Warren Street
Newark, NJ 07103
Phone: 973.577.8003
Fax: 973.577.8004
Email: contact@bioneutral.com


Daily View

Monthly View

3 Month Daily View


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BONU News: Proxy Statement - Other Information (preliminary) (pre 14c) 07/23/2014 11:56:06 AM
BONU News: Information Statement - All Other (definitive) (def 14c) 07/01/2014 08:24:48 AM
BONU News: Quarterly Report (10-q) 06/20/2014 04:14:18 PM
BONU News: Proxy Statement - Other Information (preliminary) (pre 14c) 06/19/2014 03:37:33 PM
BONU News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 06/16/2014 08:59:36 AM
#16544  Sticky Note Regarding the $150M revenue projection.... VortMax 06/12/14 10:29:35 PM
#17175   ATTENTION ALL BONU INVESTORS. If you are as Truth Taurus 07/27/14 10:29:22 PM
#17173   now that's funny, you telling someone to stop simon88 07/27/14 06:54:48 PM
#17172   $BONU watchlist lots of shares but their selling...a Quinquagintilliard 07/27/14 05:29:36 PM
#17171   Wow.... really 37 billion... thats up there with Shibbz-stock 07/27/14 08:42:08 AM
#17170   I wouldn't want this to happen but just hoggydog 07/27/14 08:35:07 AM
#17169   A simple but honest statement! honk52 07/27/14 03:41:29 AM
#17168   Who is going to buy a company with Black sunshine 07/26/14 07:58:44 PM
#17167   you are acting delusional, TT. courtpuppy 07/26/14 11:22:16 AM
#17166   I don't give a damn one way or courtpuppy 07/26/14 11:18:48 AM
#17165   Quite the contrary IMO. HAE12 07/26/14 08:00:28 AM
#17164   Because verbally abusing works? BONU PoliSci 07/26/14 06:46:09 AM
#17163   Well I have 3mill in shares @.0001, Waiting viper666 07/26/14 01:08:01 AM
#17162   Big Dog. Check with TA before spuwing garbage. malt66 07/25/14 06:56:33 PM
#17161   They have their new 30 billion shares ready hoggydog 07/25/14 05:43:23 PM
#17160   Keep yapping big dog. You'll get your share malt66 07/25/14 05:22:10 PM
#17159   You're an idiot.They have had years of nothing hoggydog 07/25/14 05:15:54 PM
#17158   Got screwed? Short term thinking is like a malt66 07/25/14 04:20:36 PM
#17157   Your previous post would make me think you hoggydog 07/25/14 04:09:24 PM
#17156   Ask thinning real fast...let's see what VFIN has malt66 07/25/14 04:06:58 PM
#17155   HA! That's a Hoot! Bite the hand that Truth Taurus 07/25/14 02:34:01 PM
#17154   Court....It sounds like you want the company to HAE12 07/25/14 02:00:00 PM
#17153   there is no feeding to anybody by BONU. courtpuppy 07/25/14 01:08:51 PM
#17152   My sentiments exactly!! There was some speculation a HAE12 07/25/14 12:33:14 PM
#17151   Don't bite the hand that feeds you... Omega3653 07/25/14 12:22:49 PM
#17150   Read the last paragraph of this article..i did elgringo 07/25/14 09:33:36 AM
#17149   excuse me but yu have to be deaf, elgringo 07/24/14 11:28:33 PM
#17148   You out?? California Chrome 07/24/14 07:52:20 PM
#17147   Vortmax still pumping this? A/S is over 30 California Chrome 07/24/14 07:50:55 PM
#17146   Don't care if you sell at $.0001 or not. courtpuppy 07/24/14 06:07:49 PM
#17145   ATTENTION ALL BONU INVESTORS. If you are as Truth Taurus 07/24/14 04:44:24 PM
#17144   ATTENTION ALL BONU INVESTORS. If you are as Truth Taurus 07/24/14 04:44:24 PM
#17140   Desperation has set in. Acceptance is next...right after bogee 07/24/14 11:26:48 AM
#17139   BONU expanding market share with http://www.nycoproducts.com/news/2014/06/bio Street_Gnocca 07/24/14 11:01:04 AM
#17138   nice work very tough one here VortMax 07/24/14 10:14:38 AM
#17137   WAIT. That Was A POSITIVE Response! I actually mulder35 07/24/14 09:05:20 AM
#17136   I posted this on NYCO Products Facebook website courtpuppy 07/24/14 08:12:58 AM
#17135   Nice. At this point I'll be in the momoney163 07/23/14 09:15:36 PM
#17134   Yeah...but you may regret it, come fall. malt66 07/23/14 09:15:14 PM
#17133   Glad I was able to escape $7 in Black sunshine 07/23/14 09:09:56 PM
#17132   Read point 1 and 3..very interesting. We all elgringo 07/23/14 07:48:27 PM
#17131   I'm not leading jackshit here. I just posted courtpuppy 07/23/14 04:17:19 PM
#17130   What are you 12? why are you name HAE12 07/23/14 04:17:05 PM
#17129   Last trade was 911 at .0002, I was HAE12 07/23/14 04:15:33 PM
#17128   LOL at the "911" print for .0002 seconds Penny Speculator 07/23/14 04:14:12 PM
#17126   NOW HE LIKES SOCIAL MEDIA LMAO , YOUR Shark Tank 07/23/14 04:09:45 PM
#17125   CourtPuppy Good Job! Keep it up... Its what mulder35 07/23/14 04:06:01 PM
#17124   Does anyone here have anything constructive to weigh HAE12 07/23/14 03:50:42 PM
#17123   I think we should flood NYCOs Facebook sight courtpuppy 07/23/14 03:36:13 PM
#17122   they just issued another 30 billion shares this ROBINJOY 07/23/14 03:35:19 PM
#17121   600 Million shares Mothers can't even go a courtpuppy 07/23/14 03:19:28 PM